Abstract
To construct a novel scaffold for nucleus pulposus (NP) tissue engineering, The porous type II collagen (CII)/hyaluronate (HyA)–chondroitin-6-sulfate (6-CS) scaffold was prepared using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) and N-hydroxysuccinimide (NHS) cross-linking system. The physico-chemical properties and biocompatibility of CII/HyA–CS scaffolds were evaluated. The results suggested CII/HyA–CS scaffolds have a highly porous structure (porosity: 94.8 ± 1.5%), high water-binding capacity (79.2 ± 2.8%) and significantly improved mechanical stability by EDC/NHS crosslinking (denaturation temperature: 74.6 ± 1.8 and 58.1 ± 2.6°C, respectively, for the crosslinked scaffolds and the non-crosslinked; collagenase degradation rate: 39.5 ± 3.4 and 63.5 ± 2.0%, respectively, for the crosslinked scaffolds and the non-crosslinked). The CII/HyA–CS scaffolds also showed satisfactory cytocompatibility and histocompatibility as well as low immunogenicity. These results indicate CII/HyA–CS scaffolds may be an alternative material for NP tissue engineering due to the similarity of its composition and physico-chemical properties to those of the extracellular matrices (ECM) of native NP.
Similar content being viewed by others
References
Andersson GB, Schultz A, Nathan A, Irstam L. Roentgenographic measurement of lumbar intervertebral disc height. Spine. 1981;6:154–8.
Yasuma T, Koh S, Okamura T, Yamauchi Y. Histological changes in aging lumbar intervertebral discs. Their role in protrusions and prolapses. J Bone Joint Surg Am. 1990;72:220–9.
Kuslich SD, Ulstrom CL, Michael CJ. The tissue origin of low back pain and sciatica: a report of pain response to tissue stimulation during operations on the lumbar spine using local anesthesia. Orthop Clin North Am. 1991;22:181–7.
Schwarzer AC, Aprill CN, Derby R, et al. The prevalence and clinical features of internal disc disruption in patients with chronic low back pain. Spine. 1995;20:1878–83.
Hutton WC, Toribatake Y, Elmer WA, et al. The effect of compressive force applied to the intervertebral disc in vivo. A study of proteoglycans and collagen. Spine. 1998;23:2524–37.
Lotz JC, Chin JR. Intervertebral disc cell death is dependent on the magnitude and duration of spinal loading. Spine. 2000;25:1477–83.
An H, Boden SD, Kang J, et al. Summary statement: emerging techniques for treatment of degenerative lumbar disc disease. Spine. 2003;28:S24–5.
Huang RC, Sandhu HS. The current status of lumbar total disc replacement. Orthop Clin North Am. 2004;35:33–42.
Inoue H. Three-dimensional architecture of lumbar intervertebral discs. Spine. 1981;6:139–46.
Yu J, Winlove CP, Roberts S, Urban JP. Elastic fibre organization in the intervertebral discs of the bovine tail. J Anat. 2002;201:465–75.
Paesold G, Nerlich AG, Boos N. Biological treatment strategies for disc degeneration: potentials and shortcomings. Eur Spine J. 2007;16:447–68.
Adler JH, Schoenbaum M, Silberberg R. Early onset of disk degeneration and spondylosis in sand rats (Psammomys obesus). Vet Pathol. 1983;20:13–22.
Wakatsuki T, Elson EL. Reciprocal interactions between cells and extracellular matrix during remodeling of tissue constructs. Biophys Chem. 2003;100:593–605.
Yang X, Li X. Nucleus pulposus tissue engineering: a brief review. Eur Spine J. 2009 [Epub ahead of print].
Moller HJ, Heinegard D, Poulsen JH. Combined alcian blue and silver staining of subnanogram quantities of proteoglycans and glycosaminoglycans in sodium dodecyl sulfate-polyacrylamide gels. Anal Biochem. 1993;209:169–75.
Zhang R, Ma PX. Porous poly(l-lactic acid)/apatite composites created by biomimetic process. J Biomed Mater Res. 1999;45:285–93.
Liu LS, Thompson AY, Heidaran MA, et al. An osteoconductive collagen/hyaluronate matrix for bone regeneration. Biomaterials. 1999;20:1097–108.
Pieper JS, Hafmans T, Veerkamp JH, et al. Development of tailor-made collagen–glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. Biomaterials. 2000;21:581–93.
Rong Y, Sugumaran G, Silbert JE, et al. Proteoglycans synthesized by canine intervertebral disc cells grown in a type I collagen–glycosaminoglycan matrix. Tissue Eng. 2002;8:1037–47.
Sato M, Kikuchi M, Ishihara M, et al. Tissue engineering of the intervertebral disc with cultured annulus fibrosus cells using atelocollagen honeycomb-shaped scaffold with a membrane seal (ACHMS scaffold). Med Biol Eng Comput. 2003;41:365–71.
Brown RQ, Mount A, Burg KJ. Evaluation of polymer scaffolds to be used in a composite injectable system for intervertebral disc tissue engineering. J Biomed Mater Res A. 2005;74:32–9.
Seguin CA, Grynpas MD, Pilliar RM, et al. Tissue engineered nucleus pulposus tissue formed on a porous calcium polyphosphate substrate. Spine. 2004;29:1299–306; discussion 1306–1297.
Chiba K, Andersson GB, Masuda K, et al. Metabolism of the extracellular matrix formed by intervertebral disc cells cultured in alginate. Spine. 1997;22:2885–93.
Baer AE, Wang JY, Kraus VB, et al. Collagen gene expression and mechanical properties of intervertebral disc cell-alginate cultures. J Orthop Res. 2001;19:2–10.
Le Visage C, Yang SH, Kadakia L, et al. Small intestinal submucosa as a potential bioscaffold for intervertebral disc regeneration. Spine. 2006;31:2423–30; discussion 2431.
Crevensten G, Walsh AJ, Ananthakrishnan D, et al. Intervertebral disc cell therapy for regeneration: mesenchymal stem cell implantation in rat intervertebral discs. Ann Biomed Eng. 2004;32:430–4.
Roughley P, Hoemann C, DesRosiers E, et al. The potential of chitosan-based gels containing intervertebral disc cells for nucleus pulposus supplementation. Biomaterials. 2006;27:388–96.
Yang SH, Chen PQ, Chen YF, et al. An in vitro study on regeneration of human nucleus pulposus by using gelatin/chondroitin-6-sulfate/hyaluronan tri-copolymer scaffold. Artif Organs. 2005;29:806–14.
Sakai D, Mochida J, Iwashina T, et al. Atelocollagen for culture of human nucleus pulposus cells forming nucleus pulposus-like tissue in vitro: influence on the proliferation and proteoglycan production of HNPSV-1 cells. Biomaterials. 2006;27:346–53.
Halloran DO, Grad S, Stoddart M, et al. An injectable cross-linked scaffold for nucleus pulposus regeneration. Biomaterials. 2008;29:438–47.
Gruber HE, Leslie K, Ingram J, et al. Cell-based tissue engineering for the intervertebral disc: in vitro studies of human disc cell gene expression and matrix production within selected cell carriers. Spine J. 2004;4:44–55.
Taguchi T, Ikoma T, Tanaka J. An improved method to prepare hyaluronic acid and type II collagen composite matrices. J Biomed Mater Res. 2002;61:330–6.
Doillon CJ, Whyne CF, Brandwein S, et al. Collagen-based wound dressings: control of the pore structure and morphology. J Biomed Mater Res. 1986;20:1219–28.
O’Brien FJ, Harley BA, Yannas IV, et al. Influence of freezing rate on pore structure in freeze-dried collagen–GAG scaffolds. Biomaterials. 2004;25:1077–86.
Charulatha V, Rajaram A. Influence of different crosslinking treatments on the physical properties of collagen membranes. Biomaterials. 2003;24:759–67.
Lee CR, Grodzinsky AJ, Spector M. The effects of cross-linking of collagen–glycosaminoglycan scaffolds on compressive stiffness, chondrocyte-mediated contraction, proliferation and biosynthesis. Biomaterials. 2001;22:3145–54.
Cao H, Xu S-Y. EDC/NHS-crosslinked type II collagen–chondroitin sulfate scaffold: characterization and in vitro evaluation. J Mater Sci: Mater Med. 2008;19:567–75.
Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials. 2000;21:2529–43.
Pieper JS, van der Kraan PM, Hafmans T, et al. Crosslinked type II collagen matrices: preparation, characterization, and potential for cartilage engineering. Biomaterials. 2002;23:3183–92.
Hunziker EB. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage. 2002;10:432–63.
Al-Munajjed AA, Hien M, Kujat R, et al. Influence of pore size on tensile strength, permeability and porosity of hyaluronan–collagen scaffolds. J Mater Sci: Mater Med. 2008;19:2859–64.
Anselme K, Bacques C, Charriere G, et al. Tissue reaction to subcutaneous implantation of a collagen sponge. A histological, ultrastructural, and immunological study. J Biomed Mater Res. 1990;24:689–703.
van Wachem PB, Plantinga JA, Wissink MJ, et al. In vivo biocompatibility of carbodiimide-crosslinked collagen matrices: effects of crosslink density, heparin immobilization, and bFGF loading. J Biomed Mater Res. 2001;55:368–78.
Gagnieu CH, Forest PO. In vivo biodegradability and biocompatibility of porcine type I atelocollagen newly crosslinked by oxidized glycogen. Biomed Mater Eng. 2007;17:9–18.
Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28:5–24.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (No. 30772186) and the Youth Science and Research Foundation of the Third Military Medical University (No. XG2005D127).
Author information
Authors and Affiliations
Corresponding author
Additional information
Chang-qing Li and Bo Huang are co-first authors. Both authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Li, Cq., Huang, B., Luo, G. et al. Construction of collagen II/hyaluronate/chondroitin-6-sulfate tri-copolymer scaffold for nucleus pulposus tissue engineering and preliminary analysis of its physico-chemical properties and biocompatibility. J Mater Sci: Mater Med 21, 741–751 (2010). https://doi.org/10.1007/s10856-009-3871-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-009-3871-5